Long-term efficacy of immunoadsorbent plasmapheresis in a patient with Budd-Chiari syndrome due to antiphospholipid syndrome: case report with nine-year follow-up.
We describe the safety and efficacy of long-term immunoadsorbent plasmapheresis (IAPP) with dextran sulfate-cellulose bead columns in antiphospholipid syndrome (APS). IAPP was administered to a 38-year old male Japanese patient with APS with Budd-Chiari syndrome (BCS), who had presented with refractory lower leg skin ulcers and arterial and venous thromboses including BCS. After hepatic vein transluminal angioplasty was performed, the combination of corticosteroid, aspirin and IAPP was administered because of an underlying bleeding tendency related to liver dysfunction. From February 1994 to February 2003, a total of 228 procedures were performed. No further thrombosis-related symptoms or bleeding have occurred for more than nine years, suggesting that IAPP with dextran sulfate cellulose columns is safe and effective for APS in preventing additional thrombotic events. This IAPP supplements anticoagulation, antiplatelet, corticosteroid and immunosuppressant therapies.
Molecular Genetics of Cardiovascular Disorders, Graduate School of Medical Science, Kanazawa University, Japan. diabe@med.kanazawa-u.ac.jp
K
K
Yagi
M
M
Kawano
T
T
Haraki
T
T
Higashikata
K
K
Ueda
T
T
Okada
I
I
Koni
H
H
Mabuchi
D000328:Adult; D016736:Antiphospholipid Syndrome / Q000150:complications*; D001241:Aspirin / Q000008:administration & dosage; D006502:Budd-Chiari Syndrome / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010956:Plasmapheresis / Q000379:methods; D011239:Prednisolone / Q000008:administration & dosage
D011239:Prednisolone; D001241:Aspirin